Evaluation of the serum creatinine to total bilirubin ratio in psoriasis patients treated with biological agents: significant reduction following IL-17 inhibitor therapy
The decrease in creatinine to total bilirubin ratio after 6 months of treatment was statistically significant only in patients treated with IL-17 inhibitors, particularly ixekizumab. Therefore, we suggest that IL-17 inhibitors may have a protective role against hypertension in patients with psoriasis.
Authors
- Funda Tamer (ORCID: https://orcid.org/0000-0003-4157-5583)
- Yusuf Can Edek (ORCID: https://orcid.org/0000-0002-3877-8681)
- Emre Güven
- Esra Adışen (ORCID: https://orcid.org/0000-0002-8768-231X)
Institutions
- British Association of Dermatologists (GB)
- University Dermatology (US)
- Gazi University (TR)
Publication Details
- Journal
- Biomarkers
- Published
- 2025-08-18
- DOI
- https://doi.org/10.1080/1354750x.2025.2568858
- Primary Topic
- Psoriasis: Treatment and Pathogenesis
- Type
- article
- Field-Weighted Citation Impact
- 0.00